KR100818010B1 - 루핀의 펩티드 추출물 및 이를 함유하는 약학 조성물,화장 조성물 또는 영양 조성물 - Google Patents

루핀의 펩티드 추출물 및 이를 함유하는 약학 조성물,화장 조성물 또는 영양 조성물 Download PDF

Info

Publication number
KR100818010B1
KR100818010B1 KR1020017013229A KR20017013229A KR100818010B1 KR 100818010 B1 KR100818010 B1 KR 100818010B1 KR 1020017013229 A KR1020017013229 A KR 1020017013229A KR 20017013229 A KR20017013229 A KR 20017013229A KR 100818010 B1 KR100818010 B1 KR 100818010B1
Authority
KR
South Korea
Prior art keywords
lupine
peptide
composition
mmp
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020017013229A
Other languages
English (en)
Korean (ko)
Other versions
KR20020030263A (ko
Inventor
시까삘립
삐씨릴리앙똔느
뽈프랑스와
Original Assignee
라보라뜨와르 엑스팡샹스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라보라뜨와르 엑스팡샹스 filed Critical 라보라뜨와르 엑스팡샹스
Publication of KR20020030263A publication Critical patent/KR20020030263A/ko
Application granted granted Critical
Publication of KR100818010B1 publication Critical patent/KR100818010B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
KR1020017013229A 1999-04-19 2000-04-18 루핀의 펩티드 추출물 및 이를 함유하는 약학 조성물,화장 조성물 또는 영양 조성물 Expired - Fee Related KR100818010B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904875A FR2792202B1 (fr) 1999-04-19 1999-04-19 Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
FR99/04875 1999-04-19
PCT/FR2000/001007 WO2000062789A1 (fr) 1999-04-19 2000-04-18 Extrait peptidique du lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait

Publications (2)

Publication Number Publication Date
KR20020030263A KR20020030263A (ko) 2002-04-24
KR100818010B1 true KR100818010B1 (ko) 2009-01-28

Family

ID=9544562

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017013229A Expired - Fee Related KR100818010B1 (ko) 1999-04-19 2000-04-18 루핀의 펩티드 추출물 및 이를 함유하는 약학 조성물,화장 조성물 또는 영양 조성물

Country Status (10)

Country Link
US (2) US7029713B2 (enExample)
EP (1) EP1171143B9 (enExample)
JP (1) JP5329731B2 (enExample)
KR (1) KR100818010B1 (enExample)
AT (1) ATE279934T1 (enExample)
DE (1) DE60015112T8 (enExample)
ES (1) ES2228500T3 (enExample)
FR (1) FR2792202B1 (enExample)
PT (1) PT1171143E (enExample)
WO (1) WO2000062789A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2548458A1 (en) * 2011-07-22 2013-01-23 HPF Nutraceutics S.r.L. Lupine-derived compounds having hypotensive activity and process for production of their production
KR20170026401A (ko) * 2014-07-03 2017-03-08 라보라토이레즈 익스펜사이언스 루핀 펩타이드 추출물들 및 피부 견실도

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813018B1 (fr) * 2000-08-21 2004-02-06 Boots Co Plc Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
FR2823440B1 (fr) * 2000-11-14 2004-06-04 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
FR2822068B1 (fr) * 2001-03-15 2004-12-17 Pharmascience Lab Composition topique comprenant une association de lipides furanniques d'avocat et d'isoflavones
FR2834216B1 (fr) * 2001-12-27 2004-04-30 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2834213B1 (fr) * 2001-12-27 2004-06-04 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2834638B1 (fr) * 2002-01-11 2004-04-02 Medix Lab Composition comprenant en association au moins un flavonoide, au moins un extrait peptidique de lupin et au moins une huile vegetale, son utilisation comme agent dermatologique ou dermo-cosmetique
KR100490212B1 (ko) * 2002-06-21 2005-05-17 주식회사 바이오랜드 피부 각질층의 아미노산 구성비율을 가지는 아미노산복합물과 그것을 함유한 노화방지 화장료 조성물
AU2003264192A1 (en) * 2002-08-30 2004-03-19 Biopharmacopae Design International Inc. Plant extracts for treatment of angiogenesis and metastasis
EP1405572A1 (en) * 2002-10-04 2004-04-07 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Modified lupin proteins for the preparation of water dispersible product forms of fat soluble compounds
FR2847473B1 (fr) 2002-11-25 2007-06-29 Expanscience Lab Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
CN100513227C (zh) * 2004-02-02 2009-07-15 大发工业株式会社 汽车用座位
FR2867074B1 (fr) * 2004-03-08 2009-10-30 Clarins Lab Composition cosmetique amincissante comprenant en tant qu'agent actif un inhibiteur de metalloproteinases
JP4815752B2 (ja) * 2004-04-01 2011-11-16 味の素株式会社 アミノ酸含有飲食品
FR2868703B1 (fr) 2004-04-08 2008-06-13 Expanscience Sa Lab Extrait total de lupin constitue d'un extrait de sucres de lupin et d'un extrait peptidique de lupin, procede d'obtention et utilisation
FR2869541B1 (fr) 2004-04-30 2007-12-28 Expanscience Sa Lab Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
DE102004043802A1 (de) * 2004-09-08 2006-03-09 Henkel Kgaa Mund- und Zahnpflege- und reinigungsmittel mit entzündungshemmender Wirkung
FR2875134B1 (fr) 2004-09-16 2007-08-24 Oreal Utilisation cosmetique d'une composition renfermant un derive ascorbique et des particules de polyamide
FR2893628B1 (fr) 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
KR100849019B1 (ko) * 2006-06-28 2008-07-29 (주)더페이스샵코리아 화이트 루핀 추출물을 함유하는 화장료 조성물
KR101245811B1 (ko) * 2006-08-18 2013-03-20 주식회사 엘지생활건강 식물 혼합 추출물인 셀리언스를 함유하는 피부노화 예방 및개선용 화장료 조성물
US7571061B2 (en) * 2007-04-17 2009-08-04 The United States Of America As Represented By The Secretary Of Agriculture Non-destructive method of measuring a moisture content profile across a hygroexpansive, composite material
EP2205719A1 (en) * 2007-09-26 2010-07-14 Celgene Cellular Therapeutics Angiogenic cells from human placental perfusate
FR2921836B1 (fr) * 2007-10-05 2013-01-18 Limousine D Applic Biolog Ditesilab Soc Ind Utilisation d'un principe actif combinant des principes actifs issus de medicago sativa et de lupinus albus pour lutter contre les poches sous les yeux
GB0921001D0 (en) 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
PH12013500692A1 (en) 2010-10-12 2013-06-03 Consumo Em Verde Biotecnologia Das Plantas S A Antimicrobial protein
FR2975004B1 (fr) 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
KR101491902B1 (ko) * 2012-04-06 2015-02-11 경남과학기술대학교 산학협력단 콜라게나제의 활성 저해 효과를 갖는 신규 펩타이드 및 그의 용도
WO2014030950A1 (ko) * 2012-08-24 2014-02-27 경상대학교 산학협력단 콜라게나제의 활성 저해 효과를 갖는 굴 가수분해물 유래 신규 펩타이드 및 그의 용도
CN105101979B (zh) 2012-12-21 2021-10-08 安斯泰来再生医药协会 由多能干细胞制备血小板的方法及其组合物
FR3001889B1 (fr) 2013-02-11 2021-02-12 Expanscience Lab Utilisation d'une composition comprenant un perseose d'avocat dans la protection des cellules souches epidermiques .
WO2014165484A2 (en) 2013-04-02 2014-10-09 Air Products And Chemicals, Inc. Compositions of delivery systems and lupine with physical stability
FR3011008B1 (fr) 2013-09-24 2017-12-29 Expanscience Lab Procedes d'evaluation des effets deleteres des uv sur la peau d'enfant
JP6209438B2 (ja) * 2013-12-19 2017-10-04 花王株式会社 水中油型乳化組成物
WO2016051000A1 (es) * 2014-09-29 2016-04-07 Consejo Superior De Investigaciones Científicas (Csic) Péptido aislado en un hidrolizado de altramuz y su uso en el tratamiento de enfermedades inflamatorias
GB2533379A (en) 2014-12-18 2016-06-22 Ipco 2012 Ltd A system and server for receiving transaction requests
WO2020192865A1 (en) * 2019-03-22 2020-10-01 Symrise Ag Plant peptides and their applications
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
DE102020104279A1 (de) 2020-02-18 2021-08-19 Gelita Ag Kollagenhydrolysat als Wirkstoff gegen Parodontitis oder Gingivitis
JP7569630B2 (ja) * 2020-05-25 2024-10-18 株式会社 資生堂 化粧料
WO2025114961A1 (en) * 2023-11-30 2025-06-05 Universita' Degli Studi Di Milano Methods to counteract skin aging

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2051017A (en) * 1932-07-09 1936-08-11 Schwarz Process for producing from plant materials protein decomposition products, mineral salts, and soluble carbohydrates
US2615905A (en) * 1949-10-31 1952-10-28 Forstmann Walther Geo Heinrich Recovering valuable components from oil bearing seeds, and products therefrom
DE3219245A1 (de) 1982-05-21 1983-11-24 Mittex Ag Duengemittel aus lupinen, verfahren zu dessen herstellung und vorrichtung zur durchfuehrung des verfahrens
US4402874A (en) * 1983-01-10 1983-09-06 Thiokol Corporation Process for the preparation of protein isolates of improved quality from vegetable protein sources using alkali metal borohydrides
JP3415198B2 (ja) * 1993-06-30 2003-06-09 三省製薬株式会社 皮膚外用剤
FR2725130B1 (fr) * 1994-09-29 1996-10-31 Oreal Compositions cosmetiques contenant un compose lipidique de type ceramide et un peptide a une chaine grasse, et leurs utilisations
DE59605147D1 (de) * 1995-10-05 2000-06-08 Finanzconsul Ag Zuerich Verfahren zur verarbeitung proteinhaltiger pflanzen
FR2739860B1 (fr) * 1995-10-17 1998-01-02 Coletica Complexes amphiphiles, procede pour leur preparation et compositions en renfermant
JPH107518A (ja) 1996-06-25 1998-01-13 Ikeda Bussan Kk 皮膚外用剤
FR2762512B1 (fr) 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
EP1090630A4 (en) * 1998-03-11 2004-06-16 Soken Kk NORMALIZING AGENTS FOR THE SKIN
FR2778565B1 (fr) * 1998-05-14 2000-07-28 Silab Sa Procede d'extraction de principes actifs vegetaux a partir de graines de lupin blanc doux, extrait obtenu et composition utilisant au moins une fraction de cet extrait
US6630163B1 (en) * 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARK E. HINES ET AL. : "SCREENING FOR CYCTEINE PROTEINASE INHIBITOR ACTIVITY IN LEGUME SEEDS" JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE., VOL59, 1992, PAGES 555-557 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2548458A1 (en) * 2011-07-22 2013-01-23 HPF Nutraceutics S.r.L. Lupine-derived compounds having hypotensive activity and process for production of their production
KR20170026401A (ko) * 2014-07-03 2017-03-08 라보라토이레즈 익스펜사이언스 루핀 펩타이드 추출물들 및 피부 견실도
KR102450968B1 (ko) * 2014-07-03 2022-10-04 라보라토이레즈 익스펜사이언스 루핀 펩타이드 추출물들 및 피부 견실도

Also Published As

Publication number Publication date
US20040101580A1 (en) 2004-05-27
DE60015112T8 (de) 2006-08-24
US7638149B2 (en) 2009-12-29
FR2792202B1 (fr) 2003-06-13
FR2792202A1 (fr) 2000-10-20
US20050148498A1 (en) 2005-07-07
US7029713B2 (en) 2006-04-18
ES2228500T3 (es) 2005-04-16
DE60015112T2 (de) 2006-02-02
PT1171143E (pt) 2005-03-31
EP1171143A1 (fr) 2002-01-16
EP1171143B9 (fr) 2005-03-16
JP5329731B2 (ja) 2013-10-30
DE60015112D1 (de) 2004-11-25
WO2000062789A1 (fr) 2000-10-26
EP1171143B1 (fr) 2004-10-20
KR20020030263A (ko) 2002-04-24
ATE279934T1 (de) 2004-11-15
JP2002542199A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
KR100818010B1 (ko) 루핀의 펩티드 추출물 및 이를 함유하는 약학 조성물,화장 조성물 또는 영양 조성물
US7470438B1 (en) Ericacea extracts for combating skin aging
KR101988675B1 (ko) 피부 및/또는 점막의 치료 및/또는 관리에 유용한 펩티드 및 화장품학적 또는 약제학적 조성물에 있어서의 이의 용도
US20120282198A1 (en) Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
FR2767833A1 (fr) Polypeptide isole de l'epiderme et son utilisation
US20030152597A1 (en) Use of at least one sapogenin for prevening the skin or ageing symptoms
KR20070003907A (ko) 혈청 노화 인자 격리 제제 및 이를 위한 용도
EP1656970A1 (fr) Composition cosmétique comprenant un hydrolysat de protéines de riz et un agent augmentant la synthèse des glycosaminoglycanes
US7838020B2 (en) Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least one matrix metalloproteinase inhibitor
US6998129B2 (en) Cosmetic or dermatological composition comprising an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one anti-inflammatory compound
FR2903903A1 (fr) Utilisation d'un hydrolysat de proteines de riz en tant que principe actif pigmentant
JP4441123B2 (ja) 加齢皮膚の徴候を処置するための組成物におけるロスマリヌス属の植物抽出物の使用
CA2330807C (fr) Utilisation d'inhibiteurs de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
EP0946138B1 (fr) Utilisation d'un extrait de potentilla erecta dans le domaine de la cosmetique et de la pharmacie
JP4689039B2 (ja) ファゴサイトーシスおよびｉｃａｍ−１発現を調節するための組成物および方法
US6056944A (en) Pharmaceutical compositions for oral use including an NSAID and ceramides
JP2004099503A (ja) Ｈｇｆ産生促進剤およびこれを含有する化粧料
US20060141078A1 (en) Composition comprising a rice protein hydrolysate and an agent for increasing glycosaminoglycan synthesis
EP1333804B1 (fr) Compositions comprenant une beta-galactosidase, une n-acetyl-glucosaminidase et une n-acetyl-galactosaminidase, lesdites compositions ne comprenant pas de protease
US20050065212A1 (en) Use of at least one 10-hydroxy-2-decenoic acid derivative in compositions for treating the cuteous signs of aging
JP4954450B2 (ja) 弾性繊維形成の不全、欠損又は無秩序による病状に対処するための、リシルオキシダーゼのアイソフォームの活性の誘導
FR2949781A1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable d'activer la transglutaminase.
TW201219044A (en) Use of porcine lung extract as Metrix Metalloproteinase inhibitor
WO2008012476A2 (fr) Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20130228

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20140227

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

FPAY Annual fee payment

Payment date: 20150225

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20170227

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180325

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180325

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000